A J Schabas,V Vukojevic,C Taylor et al.
A J Schabas et al.
Objective: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis (MS) patients who attend the University of British Columbia Hospital (UBCH) MS clinic. ...
Changes in cortical motor outputs after a motor relapse of multiple sclerosis [0.03%]
多发性硬化症运动复发后的皮质运动输出变化
Raffaella Chieffo,Laura Straffi,Alberto Inuggi et al.
Raffaella Chieffo et al.
Background: Motor recovery following a multiple sclerosis (MS) relapse depends on mechanisms of tissue repair but also on the capacity of the central nervous system for compensating of permanent damage. ...
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting [0.03%]
多发性硬化症结核筛查：疾病修正疗法和淋巴细胞减少在临床环境中对结核筛查结果不确定性的影响
Laura E Baldassari,Jenny Feng,Gabrielle Macaron et al.
Laura E Baldassari et al.
Background: Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results. ...
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis [0.03%]
高活性儿童期发病多发性硬化症的那他珠单抗治疗后的 Alemtuzumab 治疗
Monica Margoni,Francesca Rinaldi,Silvia Miante et al.
Monica Margoni et al.
We evaluated the occurrence of infusion-associated reactions, severe adverse events and no evidence of disease activity 3 status of a therapeutic course consisting of natalizumab followed by alemtuzumab in paediatric-onset multiple sclerosi...
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study [0.03%]
纵向OCT研究发现视网膜内核层体积可反映多发性硬化炎性病灶活动度
Lisanne J Balk,Danko Coric,Benjamin Knier et al.
Lisanne J Balk et al.
Background: The association of peripapillary retinal nerve fibre layer (pRNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness with neurodegeneration in multiple sclerosis (MS) is well established. The relations...
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension [0.03%]
马来酸伊莫苷在日本多发性硬化症患者中的疗效：随机双盲APEX研究和其开放标签延长试验的中期分析结果
T Kondo,I Kawachi,Y Onizuka et al.
T Kondo et al.
Background: Current data for the use of dimethyl fumarate (DMF) in Japanese patients with relapsing-remitting multiple sclerosis (RRMS) is limited. Object...
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension [0.03%]
富马酸二甲酯在日本多发性硬化症患者中的疗效：随机、双盲APEX研究的中期分析及其开放标签延长研究
T Kondo,I Kawachi,Y Onizuka et al.
T Kondo et al.
Background: Current data for the use of dimethyl fumarate (DMF) in Japanese patients with relapsing-remitting multiple sclerosis (RRMS) is limited. Object...
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis [0.03%]
急性视神经炎早期影像学预测多发性硬化风险和长期严重程度的标志物
Sanuji Gajamange,Jim Stankovich,Gary Egan et al.
Sanuji Gajamange et al.
Background: Biomarkers are urgently required for predicting the likely progression of multiple sclerosis (MS) at the earliest stages of the disease to aid in personalised therapy. ...
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis [0.03%]
急性视神经炎早期影像学预测多发性硬化风险和长期严重程度的标志物
Sanuji Gajamange,Jim Stankovich,Gary Egan et al.
Sanuji Gajamange et al.
Background: Biomarkers are urgently required for predicting the likely progression of multiple sclerosis (MS) at the earliest stages of the disease to aid in personalised therapy. ...
Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in Sweden [0.03%]
瑞典一项基于人群的多发性硬化症不同分型疾病进展成本研究
Hanna Gyllensten,Andrius Kavaliunas,Chantelle Murley et al.
Hanna Gyllensten et al.
Background: Little is known of how the cost of illness and health-related quality of life changes over time after a diagnosis of multiple sclerosis. Objec...